Nektar Therapeutics
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.1% | -34.0% | +39.9% | +342.1% | -37.6% | -60.2% | +2,761.1% | -97.4% | +43.5% | -29.1% | -17.4% | +25.3% | +15.9% | +49.4% | -3.4% | -38.5% | -21.9% | +0.8% | +19.8% | -12.0% | +0.4% | -0.7% | -13.0% | +9.5% | -6.8% | -1.9% | -5.1% | +17.8% | -1.1% | -9.4% | +8.5% | +2.7% | +20.9% | -64.1% | +6.8% | +5.5% | +85.0% | -50.2% | -6.7% | – | |
| – | -6.1% | -7.2% | +46.6% | -36.9% | +71.9% | -31.9% | -16.9% | -13.4% | +56.0% | -27.1% | -7.8% | -1.8% | +21.6% | -36.4% | +51.5% | -3.5% | -22.4% | +33.1% | +33.2% | -30.7% | +16.0% | -13.8% | -3.8% | -2.8% | +25.4% | +13.3% | -0.9% | +77.7% | -41.4% | +17.2% | +14.1% | -54.5% | +79.9% | -94.7% | -49.8% | -8.4% | -100.0% | – | – | – | |
| – | +5.3% | -39.7% | +37.7% | +475.2% | -41.8% | -63.4% | +3,349.6% | -97.9% | +40.8% | -29.6% | -19.7% | +32.8% | +14.7% | +67.8% | -7.9% | -43.2% | -21.8% | -6.5% | +15.5% | -5.1% | -3.9% | +3.5% | -15.6% | +13.3% | -15.3% | -8.0% | -7.1% | -13.3% | +41.7% | -21.1% | +4.9% | +43.2% | +7.7% | -50.7% | +6.8% | +3.7% | +88.1% | -50.9% | -5.4% | – | |
| – | -3.3% | +21.6% | -1.3% | +9.1% | +23.9% | +22.1% | -11.2% | +16.5% | +5.8% | +8.8% | -9.9% | -7.2% | +11.4% | -1.3% | -11.5% | +4.2% | +2.2% | -6.9% | +6.0% | +2.4% | -4.0% | +7.7% | -60.2% | -21.4% | +3.4% | -12.3% | -2.6% | -18.9% | +24.4% | -8.5% | +8.5% | +17.9% | -17.9% | +6.0% | -1.9% | -8.8% | +9.0% | +20.1% | +9.7% | – | |
| – | +24.5% | -6.1% | +33.6% | -24.6% | +2.3% | +51.5% | +8.4% | -7.6% | +27.0% | +5.2% | -9.7% | +6.2% | +13.2% | -3.4% | -7.1% | +10.8% | +0.6% | +16.7% | -6.7% | -0.3% | +9.1% | -14.9% | -24.9% | +9.8% | -2.6% | -3.9% | -15.2% | +18.3% | -18.1% | +16.3% | +1.8% | -7.6% | -9.6% | +42.1% | -29.9% | -7.0% | -28.3% | +18.1% | -5.0% | – | |
| – | +1.3% | +15.9% | +4.4% | +2.0% | +20.6% | +26.0% | -8.1% | +12.0% | +9.1% | +8.1% | -9.9% | -4.8% | +11.8% | -1.7% | -10.7% | +5.6% | +1.8% | -2.0% | +2.8% | +1.8% | -1.1% | +2.2% | -53.0% | -11.3% | +1.0% | +163.3% | -57.0% | -11.7% | -11.4% | -3.2% | +30.9% | -14.9% | -87.3% | +702.8% | -13.8% | -9.0% | -5.2% | +19.7% | +7.2% | – | |
| – | – | – | – | – | -134.6% | – | – | -110.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -410.4% | – | – | – | – | – | – | |
| – | -1.7% | -3.7% | +0.7% | -0.1% | +9.5% | -5.5% | +0.0% | -1.0% | +15.1% | -4.3% | -0.8% | +0.3% | +12.3% | +4.4% | -44.3% | +14.8% | -2.9% | +62.5% | -1.6% | -2.2% | -36.5% | -7.4% | -4.0% | -3.8% | +3.6% | -11.1% | -4.0% | -3.9% | +16.2% | -19.5% | +15.9% | -6.1% | +68.7% | -51.0% | +8.4% | +12.1% | +61.6% | -18.7% | -9.3% | – | |
| – | – | – | – | – | -155.1% | – | – | -109.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -825.9% | – | – | – | – | – | – | |
| – | +218.7% | -70.0% | -25.6% | +104.0% | -9.9% | +45.6% | +1,366.0% | -123.2% | – | – | – | – | -13.7% | -28.1% | -28.0% | -85.4% | +509.5% | -28.1% | +288.0% | -68.6% | -103.6% | – | -20.6% | -255.0% | – | -102.0% | – | – | – | – | – | -80.4% | -2,977.8% | – | -461.5% | – | – | +106.5% | -96.9% | – | |
| – | – | – | – | – | -155.6% | – | – | -109.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -800.8% | – | – | – | – | – | – | |
| – | – | – | – | – | -126.7% | – | – | -108.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -334.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.